The CanDetect team has several studies underway. Together, these studies will contribute towards the development and evaluation of an electronic clinical decision support tool – called a multi-cancer early detection (MCED) Platform – to help family doctors detect possible UGI cancers as early as possible. The MCED Platform will combine clinical, biomarker and imaging information to help identify patients who need rapid access to further testing or hospital care and those who can be reassured and looked after by their family doctor.

Patients with non-specific symptoms will benefit from a ‘local, smart, one-stop’ diagnostic approach, for rapid triage and appropriate management in their primary care community setting. If the UGI MCED Platform proves effective, feasible and acceptable, we will aim to apply for funding for a large trial in primary care.

The CanDetect programme has three interrelated workstreams.